15.1 Periodontal Pathogenesis, Etiology, and Disease Classification

6.1 Periodontal Pathogenesis, Etiology, and Disease Classification

Periodontal disease is a complex, multifactorial inflammatory condition initiated by a dysbiotic subgingival microbial biofilm and propagated by a destructive host immune response. On the INBDE, candidates must master the transition from bacterial etiology to host-mediated destruction, quantify local and systemic risk factors, apply the 2017 AAP/EFP Staging and Grading Classification System, and recognize acute necrotizing conditions.

---

Biofilm Pathogenesis and Primary Etiologic Factors

While hundreds of bacterial species inhabit the oral cavity, periodontitis develops when the symbiotic biofilm shifts into a pathogenic, dysbiotic state. Dental plaque biofilm is the primary etiologic factor required for periodontal inflammation; however, the bacteria alone do not directly destroy the majority of periodontal attachment. Instead, bacterial components trigger a persistent host inflammatory response.

Microbial Complexes (Socransky's Model)

Socransky grouped periodontal microorganisms into color-coded complexes based on their association with disease severity and chronological colonization:

INBDE High-Yield Trap: Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans or A.a.) is a Gram-negative facultative anaerobic rod strongly implicated in Localized Aggressive Periodontitis (now classified as Periodontitis with a Molar/Incisor pattern, Grade C). A.a. produces a potent leukotoxin that selectively destroys human polymorphonuclear leukocytes (PMNs / neutrophils) and monocytes.

---

Host Inflammatory Response & Mediators of Tissue Destruction

The host immune response is designed to contain microbial invasion, but chronic over-activation results in enzymatic breakdown of extracellular matrix and osteoclast-mediated alveolar bone loss. Polymorphonuclear leukocytes (PMNs / neutrophils) are the first line of cellular defense in the gingival sulcus. Functional PMN defects (e.g., impaired chemotaxis or phagocytosis seen in Leukocyte Adhesion Deficiency or Papillon-Lèfevre syndrome) lead to rapid, destructive periodontitis.

Key Inflammatory Mediators

1. Interleukin-1 (IL-1) & Tumor Necrosis Factor-alpha (TNF-$\alpha$): Pro-inflammatory cytokines secreted by macrophages and monocytes. They stimulate endothelial cell adhesion, induce matrix metalloproteinases, and stimulate bone resorption.
2. Prostaglandin E2 (PGE2): Derived from arachidonic acid via the cyclooxygenase-2 (COX-2) pathway. $PGE_2$ is a potent mediator of vasodilation, vascular permeability, and osteoclast activation, causing direct alveolar bone loss.
3. Matrix Metalloproteinases (MMPs): A family of zinc-dependent enzymes. MMP-8 (collagenase) is produced primarily by PMNs and is the chief enzyme responsible for the cleavage of Type I collagen, driving connective tissue destruction in the gingival corium and periodontal ligament.
4. RANKL / OPG Axis: Osteoblast-derived RANKL (Receptor Activator of Nuclear Factor-$\kappa$B Ligand) binds to RANK receptors on pre-osteoclasts, triggering osteoclast maturation and bone resorption. Osteoprotegerin (OPG) acts as a soluble decoy receptor that binds RANKL, inhibiting osteoclastogenesis. In active periodontitis, the RANKL:OPG ratio is markedly elevated.

---

Systemic and Local Risk Factors

Risk factors alter host susceptibility, disease severity, and treatment response. The INBDE frequently tests the distinction between modifiable systemic risk factors and local predisposing factors.

Systemic Risk Factors

• Smoking (Tobacco Use): The single most significant modifiable risk factor, increasing the risk for severe periodontitis by 2 to 6 times. Nicotine induces peripheral vasoconstriction, impairing gingival blood flow. Consequently, smokers exhibit suppressed bleeding on probing (BOP) despite deep pockets, impaired PMN chemotaxis, impaired fibroblast function, and reduced response to non-surgical and surgical therapy.
• Uncontrolled Diabetes Mellitus: A bidirectional relationship exists between diabetes and periodontitis. Hyperglycemia ($HbA1c > 7.0%$) leads to the accumulation of Advanced Glycation End-products (AGEs) binding to cell receptors (RAGE), triggering chronic hyper-inflammatory cytokine release, microvascular damage, impaired PMN function, and accelerated bone loss.
• Hormonal Changes & Stress: Pregnancy (associated with increased Prevotella intermedia and pregnancy gingivitis), systemic stress (elevated cortisol suppressing cell-mediated immunity), and genetic polymorphisms (e.g., IL-1 gene polymorphism).

Local Predisposing Factors

Local factors do not initiate periodontitis independently but act as plaque traps:

• Subgingival Calculus: Mineralized biofilm acting as a rough, porous reservoir for active unmineralized bacterial plaque.
• Iatrogenic Factors: Overhanging restoration margins, open contact points leading to food impaction, and subgingival crown margins.
• Anatomical Variations: Cervical enamel projections (CEPs), enamel pearls, palatogingival grooves (common on maxillary lateral incisors), and root concavities.

---

2017 AAP/EFP Periodontal Disease Classification

The 2017 World Workshop classification categorizes periodontitis into Staging (severity, extent, and complexity) and Grading (rate of disease progression, systemic risk factors, and biological features).

Periodontitis Staging (Stages I–IV)

Staging is primarily determined by clinical attachment loss (CAL) at the site of greatest loss, radiographic bone loss (RBL), and tooth loss due to periodontitis:

Extent and Pattern Descriptors: Add Localized ($<30%$ of teeth involved), Generalized ($\ge 30%$ of teeth involved), or Molar-Incisor Pattern (classic aggressive distribution targeting first molars and incisors).

Periodontitis Grading (Grades A–C)

Grading assesses the biological rate of progression and modifies the stage based on systemic risk factors:

---

Necrotizing Periodontal Diseases (NPD)

Necrotizing Periodontal Diseases comprise Necrotizing Ulcerative Gingivitis (NUG) and Necrotizing Ulcerative Periodontitis (NUP), distinguished primarily by loss of attachment and alveolar bone in NUP.

Clinical Presentation & Diagnostic Triad

NPD is characterized by an acute inflammatory presentation with a mandatory clinical triad:

1. Punched-Out Papillary Necrosis: Interdental papillae exhibit cratered, ulcerated necrosis covered by a grayish-white pseudomembrane (composed of fibrin, necrotic tissue, leukocytes, and bacteria).
2. Severe, Rapid-Onset Pain: Intense localized pain that limits eating and oral hygiene.
3. Spontaneous or Profuse Bleeding: Hemorrhage upon minimal tactile stimulation.

Secondary Features: Fetor oris (a distinctive foul, metallic odor), regional lymphadenopathy, fever, and malaise.

Etiology and Predisposing Factors

NPD is driven by an opportunistic anaerobic bacterial complex predominantly composed of Spirochetes (e.g., Treponema denticola), Prevotella intermedia, and Fusobacterium species. Key predisposing factors include severe psychological stress, sleep deprivation, malnutrition, heavy smoking, and severe immunosuppression (e.g., HIV/AIDS, where NUP can signal rapid CD4 cell decline).

Clinical Management Protocol

1. First Visit (Acute Phase): Gentle superficial debridement with warm water or ultrasonic instrumentation, topical/local anesthesia, and removal of pseudomembrane with cotton pellets soaked in $3%$ hydrogen peroxide.
2. Home Care Rinses: $0.12%$ Chlorhexidine gluconate BID or warm dilute hydrogen peroxide rinses.
3. Systemic Antibiotic Therapy: Indicated ONLY if systemic involvement (fever, lymphadenopathy, malaise) is present. Metronidazole (250 mg TID or 500 mg BID for 7 days) is the drug of choice due to its potent anti-spirochetal spectrum.